Fibristal Tablet contains Ulipristal acetate 5mg, a selective progesterone receptor modulator used primarily for the treatment of uterine fibroids in women of reproductive age. It works by modulating the effects of progesterone, a hormone involved in the growth of fibroids, thereby reducing their size and associated symptoms such as heavy menstrual bleeding, pelvic pain, and pressure. Fibristal is typically prescribed as a short-term treatment to improve quality of life and reduce the need for surgical intervention. The tablet is taken orally, usually once daily, and treatment duration is determined by a healthcare professional based on individual patient needs. Common side effects may include headache, nausea, abdominal pain, and fatigue, but these are generally mild and transient. It is important to use Fibristal under medical supervision, especially in women with liver impairment or those who are pregnant or breastfeeding, as its safety in these populations has not been established. Regular monitoring through clinical evaluation and imaging may be recommended during therapy to assess response and detect any adverse effects. Fibristal offers an effective non-surgical option for managing symptomatic uterine fibroids, improving patient comfort and reproductive health.